Ameriprise’s Aceragen Inc ACGN Stock Holding History

Ameriprise’s Portfolio ACGN Stock Details ACGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-10	Closed	-$15K	–	3794
2018 Q2	$15K	Sell	10 -5	-33%	-$9.33K	﹤0.01%	3621
2018 Q1	$29K	Sell	15 -14	-48%	-$30.7K	﹤0.01%	3603
2017 Q4	$66K	Buy	+29	New	+$66.3K	﹤0.01%	3586
2014 Q3	–	Hold	0	–	–	–	5922
2014 Q2	–	Hold	0	–	–	–	5679

Other funds holding ACGN

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Ameriprise's ACGN Position: Q3 2018 in Review

Ameriprise sold out of Aceragen Inc (ACGN) in Q3 2018, closing a stake of 10 shares — an estimated $15K sold.

Ameriprise first reported a position in ACGN in Q4 2017 and held it in 3 quarters. The position peaked at $66K in Q4 2017. 72 funds tracked by Wall St. Rank hold ACGN as of Q3 2018.

Ameriprise reported no remaining Aceragen Inc position as of Q3 2018 after selling out during the quarter.
Ameriprise sold 10 Aceragen Inc shares in Q3 2018, an estimated $15K.
Ameriprise first reported a position in Aceragen Inc in Q4 2017 and held it in 3 quarters.
Ameriprise's Aceragen Inc position peaked at $66K in Q4 2017.
72 funds tracked by Wall St. Rank held Aceragen Inc as of Q3 2018.

Based on Ameriprise's 13F filing for Q3 2018, filed 14 Nov 2018.